Yasunori Murata

Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer

Takashi Hirose, Yasunori Murata, Yasunari Oki et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2012 · 65 citations · Full text

Medicine, Circulating Tumor Cells, Metronomic Therapy +13

Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation

Toshimitsu Yamaoka, Tohru Ohmori, Motoi Ohba et al. · Molecular Cancer Research · 2017 · 46 citations · Full text

Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer

Takashi Hirose, Ken‐ichi Fujita, Sojiro Kusumoto et al. · Lung Cancer · 2016 · 38 citations

Oncology, Medicine, Pathology +8

Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.

Kentaro Okuda, Takashi Hirose, Yasunari Oki et al. · PubMed · 2012 · 33 citations

Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation

Toshimitsu Yamaoka, Tohru Ohmori, Motoi Ohba et al. · Molecular Cancer Therapeutics · 2016 · 29 citations · Full text

Pathology, Combination Met-tki/egfr-tki Exposure, Nsclc Treatment +19